×
About 15,126 results

ALLMedicine™ Malignant Melanoma Center

Research & Reviews  7,289 results

Sarcoid-like reaction: a unique response to immunotherapy in malignant melanoma.
https://doi.org/10.1136/bcr-2021-243723
BMJ Case Reports; Khalid T, Patil A et. al.

May 29th, 2021 - In recent years, immunotherapy has revolutionised the treatment landscape for oncology patients with improved survival rates in cancers which previously had a dismissal prognosis. These agents target specific pathways of inhibition such as program...

CD63 expression in metastatic melanoma and melanocytic nevi in lymph nodes.
https://doi.org/10.1016/j.prp.2021.153464
Pathology, Research and Practice; Mejia O, Vazquez T et. al.

May 29th, 2021 - Lymph node status remains one of the most important determinants for prognosis in patients with invasive malignant melanoma. Immunohistochemical stains are routinely employed in the histopathologic evaluation of sentinel lymph nodes removed for st...

see more →

Guidelines  15 results

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunother...
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0362-6
Sullivan, R.

May 29th, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien.

Behavioral Counseling to Prevent Skin Cancer
https://jamanetwork.com/journals/jama/fullarticle/2675556
David C. Grossman

May 19th, 2018 - Skin cancer is the most common type of cancer in the United States. Although invasive melanoma accounts for only 2% of all skin cancer cases, it is responsible for 80% of skin cancer deaths.

Skin Cancer Prevention: Behavioral Counseling
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/skin-cancer-counseling2
US Preventive Services Task Force

Mar 30th, 2018 - The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin can.

Sentinel Lymph Node Biopsy for Melanoma
http://ascopubs.org/doi/full/10.1200/JCO.2017.75.7724
Sandra L. Wong

Jan 31st, 2018 - To update the American Society of Clinical Oncology (ASCO)-Society of Surgical Oncology (SSO) guideline for sentinel lymph node (SLN) biopsy in melanoma.

SEOM clinical guideline for the management of malignant melanoma (2017).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785602
Clinical & Translational Oncology : Official Publication ... Berrocal A, Arance A et. al.

Nov 8th, 2017 - All melanoma suspected patients must be confirmed histologically and resected. Sentinel node biopsy must be done when tumor is over 1 mm or if less with high-risk factors. Adjuvant therapy with interferon could be offered for patients with high-ri...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  7,517 results

Lifileucel Promising Against Unresponsive Malignant Melanoma
https://www.medscape.com/viewarticle/952183

Jun 1st, 2021 - NEW YORK (Reuters Health) - Lifileucel shows promise in metastatic-melanoma patients whose disease had progressed on standard immune-checkpoint inhibitors (ICI) and other therapies, according to a small open-label trial. "Lifileucel is a ground-br...

Sarcoid-like reaction: a unique response to immunotherapy in malignant melanoma.
https://doi.org/10.1136/bcr-2021-243723
BMJ Case Reports; Khalid T, Patil A et. al.

May 29th, 2021 - In recent years, immunotherapy has revolutionised the treatment landscape for oncology patients with improved survival rates in cancers which previously had a dismissal prognosis. These agents target specific pathways of inhibition such as program...

see more →

News  297 results

Lifileucel Promising Against Unresponsive Malignant Melanoma
https://www.medscape.com/viewarticle/952183

Jun 1st, 2021 - NEW YORK (Reuters Health) - Lifileucel shows promise in metastatic-melanoma patients whose disease had progressed on standard immune-checkpoint inhibitors (ICI) and other therapies, according to a small open-label trial. "Lifileucel is a ground-br...

Cancer Diagnoses Delayed Among Prisoners in Washington State
https://www.medscape.com/viewarticle/951001

May 11th, 2021 - The lesion started out small, maybe the size of a Q-tip, but then rapidly progressed to the size of a half dollar and then a silver dollar. Michael Boswell tried to bring it to the attention of the medical staff at the Washington State Penitentiar...

ICI for Cancer Ups Cardiac Event Risk: Danish Data
https://www.medscape.com/viewarticle/943003

Dec 20th, 2020 - Immune checkpoint inhibitors (ICIs) increase the risk of cardiac events, including fatal heart attack and stroke, in patients with cancer, an analysis of Danish national registry data suggests. About 10% of 743 registry participants with lung canc...

Quiz: Test Your Knowledge on Cancer Referrals for Children and Young Adults
https://www.medscape.com/viewarticle/939423_5

Oct 21st, 2020 - A person with suspected malignant melanoma should be referred for an appointment within 2 weeks using a suspected cancer pathway if they have a suspicious pigmented skin lesion with a weighted 7-point checklist score of: Your Peers Chose: 5 or mor...

Fast Five Quiz: Malignant Melanoma
https://reference.staging.medscape.com/viewarticle/936083_1

Aug 20th, 2020 - A melanoma is a tumor produced by the malignant transformation of melanocytes and is most commonly cutaneous. Although melanoma accounts for a very small percentage of all skin cancers, it is responsible for the most skin cancer-related deaths. Th...

see more →

Patient Education  1 results see all →